Faculty Information - Takuya Murata

（Last updated : 2024-05-30 13:07:10）

Takuya Murata
Department Kawasaki Medical School Kawasaki Medical School, Department of Obstetrics and Gynecology 1,

Position Associate Professor

■ Journal

1.	2023/06	Three Cases of Appendiceal Goblet Cell Adenocarcinoma in Our Institution
2.	2022/02	An artificial intelligence-assisted diagnostic system improves the accuracy of image diagnosis of uterine cervical lesions
3.	2021/09/29	A Case of Rare Matrix-producing Triple-negative Breast Carcinoma for Which Drug Response in a Patient-derived Orthotopic Xenograft Mouse Model Was Correlated With Patient Response
4.	2021/03/25	Oral recombinant methioninase combined with paclitaxel arrests recalcitrant ovarian clear cell carcinoma growth in a patient-derived orthotopic xenograft(PDOX)nude-mouse model
5.	2020/11	Co-implantation of Tumor and Extensive Surrounding Tissue Improved the Establishment Rate of Surgical Specimens of Human-Patient Cancer in Nude Mice:Toward the　Goal of Universal Individualized Cancer Therapy
6.	2020/05	Eribulin Regresses a Cisplatinum-resistant R are-type Triple-negative Matrix-producing Breast C arcinoma Patient-derived Orthotopic Xenograft Mouse Model
7.	2019/06	Tumor-targeting Salmonella typhimurium A1-R overcomes nab-paclitaxel resistance in a cervical cancer PDOX mouse model.
8.	2017/01	Cervical Cancer Patient-Derived Orthotopic Xenograft (PDOX) Is Sensitive to Cisplatinum and Resistant to Nab-paclitaxel.
9.	2017/01	Cervical Cancer Patient-Derived Orthotopic Xenograft (PDOX) Is Sensitive to Cisplatinum and Resistant to Nab-paclitaxel.
10.	2017/01	Reconstitution of a metastatic-resistant tumor microenvironment with cancer-associated fibroblasts enables metastasis.
11.	2017	Gene expression profile showed upregulation of immune-related genes in cancer-associated fibroblast isolated from uterine cervical cancer through interaction with cancer cell.
12.	2015/02	Establishment of a patient-derived orthotopic Xenograft (PDOX) model of HER-2-positive cervical cancer expressing the clinical metastatic pattern.
13.	2015/01	Invasion of uterine cervical squamous cell carcinoma cells is facilitated by locoregional interaction with cancer-associated fibroblasts via activating transforming growth factor-beta.
14.	2011/11/01	HB-EGF and PDGF mediate reciprocal interactions of carcinoma cells with cancer-associated fibroblasts to support progression of uterine cervical cancers.
15.	2011	The significance of FDG-PET/CT for the differential diagnosis of ovarian benign, borderline, and malignant tumors.
16.	2010/07	Anti-human HB-EGF monoclonal antibodies inhibiting ectodomain shedding of HB-EGF and diphtheria toxin binding.
17.	2007/05/15	Down-regulation of insulin-like growth factor binding protein-5 (IGFBP-5): novel marker for cervical carcinogenesis.
18.	1993/05	Production of poly(L-aspartyl-L-phenylalanine) in Escherichia coli.
19.	1991/01	Site-directed mutagenesis of phosphoenolpyruvate carboxylase from E. coli: the role of His579 in the catalytic and regulatory functions.
20.	1986/02/26	Cloning and sequence analysis of cDNA encoding active phosphoenolpyruvate carboxylase of the C4-pathway from maize.
Display 5 items
Display all(20)